These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14587209)

  • 21. What is the best hepatitis B vaccination strategy for South Africa?
    Karim SS
    S Afr Med J; 1998 Jun; 88(6):693-4. PubMed ID: 9687844
    [No Abstract]   [Full Text] [Related]  

  • 22. [WHO spearheads global initiative to eradicate hepatitis B].
    Sylvan S
    Lakartidningen; 2000 Aug; 97(35):3738-40. PubMed ID: 11016226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program.
    Gîlca V; Duval B; Boulianne N; Dion R; De Serres G
    Pediatr Infect Dis J; 2006 Apr; 25(4):372-4. PubMed ID: 16567995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparing for the next public debate: universal vaccination against hepatitis B.
    Houweling H; Spaendonck MC; Paulussen T; Verweij M; Ruitenberg EJ
    Vaccine; 2011 Nov; 29(48):8960-4. PubMed ID: 21945254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Updated STIKO vaccination recommendations published].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2013 Sep; 36(9):317. PubMed ID: 24069644
    [No Abstract]   [Full Text] [Related]  

  • 26. Report of the Hepatitis B Working Group.
    Can Commun Dis Rep; 1994 Jul; 20(13):105-12. PubMed ID: 7920361
    [No Abstract]   [Full Text] [Related]  

  • 27. Universal hepatitis B vaccination of UK adolescents: a feasibility and acceptability study.
    Bramley JC; Wallace LA; Ahmed S; Duff R; Carman WF; Cameron SO; Kitchin NR; Watson MW; Goldberg DJ
    Commun Dis Public Health; 2002 Dec; 5(4):318-20. PubMed ID: 12564249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptability of universal hepatitis B vaccination among school pupils and parents.
    Hinds A; Cameron JC
    Commun Dis Public Health; 2004 Dec; 7(4):278-82. PubMed ID: 15779789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
    Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
    JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combined prevention of hepatitis A and B].
    Fortschr Med; 1997 May; 115(13):18. PubMed ID: 9324474
    [No Abstract]   [Full Text] [Related]  

  • 31. Integration of hepatitis B vaccination into national immunisation programmes. Alternative strategies must be considered before universal vaccination is adopted.
    Dunn J; Shukla R; Neal K
    BMJ; 1997 Jul; 315(7100):121-2. PubMed ID: 9240065
    [No Abstract]   [Full Text] [Related]  

  • 32. Reply to "Preparing for the next public debate: universal vaccination against hepatitis B".
    van Rijswoud E
    Vaccine; 2012 Apr; 30(17):2709. PubMed ID: 22178102
    [No Abstract]   [Full Text] [Related]  

  • 33. [National hepatitis B vaccination closer to implementation, but not soon enough; recommendations from the Dutch Health Council].
    Galama JM
    Ned Tijdschr Geneeskd; 2001 Jul; 145(28):1339-42. PubMed ID: 11484429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of the Viral Hepatitis Prevention Board--VHPB.
    McCloy E; Meheus A
    Vaccine; 1998 Nov; 16 Suppl():S7-10. PubMed ID: 9915025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An ethical argument in favour of routine hepatitis B vaccination in very low-incidence countries.
    Dawson AJ
    Lancet Infect Dis; 2005 Feb; 5(2):120-5. PubMed ID: 15680782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B vaccination coverage and risk factors associated with incomplete vaccination of children born to hepatitis B surface antigen-positive mothers, Denmark, 2006 to 2010.
    Kunoee A; Nielsen J; Cowan S
    Euro Surveill; 2016; 21(7):pii=30136. PubMed ID: 26923681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination.
    Zhang L; Xu A; Yan B; Song L; Li M; Xiao Z; Xu Q; Li L
    Int J Infect Dis; 2010 Jun; 14(6):e483-8. PubMed ID: 19939719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis B vaccination strategies].
    Kammerlander R; Zimmermann H; Vaudaux B
    Soz Praventivmed; 1998; 43 Suppl 1():S41-3, S115-7. PubMed ID: 9833265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Public vaccination programmes against hepatitis B in The Netherlands: assessing whether a targeted or a universal approach is appropriate.
    Houweling H; Wittevrongel CF; Verweij M; Ruitenberg EJ;
    Vaccine; 2010 Nov; 28(49):7723-30. PubMed ID: 20933042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.